Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

147.31 2.03 −1.36%
Market cap
$10.6B
P/E
25.6×
Fwd P/E
20.7×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a

Align Technology, Inc. (ALGN) Shares outstanding

Alert me on Shares outstanding

Align Technology, Inc.'s shares outstanding at the end of fiscal 2025 was $72.6M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $71.5M. Over the past ten years it has ranged from $72.6M (fiscal 2025) to $81.8M (fiscal 2017) — the current reading is the lowest in ten years. Align Technology, Inc. ranks 19th of 50 Medical Instruments & Supplies companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $72.6M (3.21%)
FY2024 $75.0M (2.06%)
FY2023 $76.6M (2.36%)
FY2022 $78.4M (1.57%)
FY2021 $79.7M 0.56%
FY2020 $79.2M (1.09%)
FY2019 $80.1M (1.55%)
FY2018 $81.4M (0.58%)
FY2017 $81.8M 0.43%
FY2016 $81.5M (0.05%)

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $71.5M (0.13%)
Mar 2026 $71.6M (1.34%)
Dec 2025 $72.6M 0.23%
Sep 2025 $72.4M (0.24%)
42 more quarters

Against its own ten years

Low $72.6M High $81.8M
Ten-year median $79.7M
Current reading's percentile 9

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on ALGN